In this week’s pharmaphorum digital health round-up we look at Akili’s therapeutic video game, the unveiling of next-gen medical imaging tech by NVIDIA, a new blockcha
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh